Fileey
liked
$Veracyte (VCYT.US)$
The extensive validation of Veracyte's Decipher platform at ASCO GU 2025, supported by 17 abstracts and publication in Annals of Oncology, represents a significant strengthening of the company's market position in cancer diagnostics. The data demonstrates three important commercial advantages:
First, the Decipher Prostate test's ability to predict treatment response in the NRG Oncology/RTOG 0534 trial provides a clear clinical utility case for insura...
The extensive validation of Veracyte's Decipher platform at ASCO GU 2025, supported by 17 abstracts and publication in Annals of Oncology, represents a significant strengthening of the company's market position in cancer diagnostics. The data demonstrates three important commercial advantages:
First, the Decipher Prostate test's ability to predict treatment response in the NRG Oncology/RTOG 0534 trial provides a clear clinical utility case for insura...
5
Fileey
liked
$SPDR S&P 500 ETF (SPY.US)$
JC’s DAILY MORNING BREW – FEBRUARY 15, 2025
“Inflation Is Transitory” – A Statement Aging Like Milk
BREAKING: Markets are discovering—once again—that inflation doesn’t just disappear because the Fed says so.
The latest PPI print was hotter than Powell’s discomfort level at a Senate hearing, and suddenly, all those confident rate cut predictions aged like a GameStop YOLO trade in...
JC’s DAILY MORNING BREW – FEBRUARY 15, 2025
“Inflation Is Transitory” – A Statement Aging Like Milk
BREAKING: Markets are discovering—once again—that inflation doesn’t just disappear because the Fed says so.
The latest PPI print was hotter than Powell’s discomfort level at a Senate hearing, and suddenly, all those confident rate cut predictions aged like a GameStop YOLO trade in...
13
2
4
Fileey
liked
Fileey
liked
Fileey
liked
$Appen Ltd (APX.AU)$ 【Conclusion】Do not chase APX in the short term, wait for a low entry opportunity!
🚫 Not suitable for buying at the moment, but if it drops to 2.65-2.70 AUD and stabilizes, you can consider lurking.
【Professional Analysis】
Analysis of the trend: There is a high probability of short-term adjustment, do not chase the high.
• Today's decline of -3.12%, closing at 2.79, lower than yesterday's 2.88, showing obvious short-term pressure.
• The highest 2.965 attempts to push higher, but failed to hold, forming an upper shadow line, indicating significant selling pressure.
• The lowest point is 2.76, if broken, there might be a short-term retracement to 2.65-2.70.
📊 Technical analysis: There is support, but lacks breakthrough momentum.
• MA20 (2.642) is the first support level, if broken, look at the 2.60 level.
• MA250 (1.320) is much lower than the current stock price, indicating that it is still in a long-term rebound phase, but lacks the characteristics of a strong uptrend.
• Volume 8.483 million, decreased compared to the previous few days, indicating intensified wait-and-see sentiment between longs and shorts.
⚠️ Key variable: 2/26 Earnings Reports
• Before the Earnings Reports, there may be market games. If the Earnings Reports are not good, there may be a direct plunge, so short-term caution is even more important.
• If the Volume breaks through 2.96 before the Earnings Reports, short-term follow-up can be considered, otherwise, it is safer to wait until after the Earnings Reports to operate.
Smart strategy of senior stock investor
📌 Conservative strategy (buy low and wait for stability)
✅ Consider buying only after it stabilizes at 2.65-2.70...
🚫 Not suitable for buying at the moment, but if it drops to 2.65-2.70 AUD and stabilizes, you can consider lurking.
【Professional Analysis】
Analysis of the trend: There is a high probability of short-term adjustment, do not chase the high.
• Today's decline of -3.12%, closing at 2.79, lower than yesterday's 2.88, showing obvious short-term pressure.
• The highest 2.965 attempts to push higher, but failed to hold, forming an upper shadow line, indicating significant selling pressure.
• The lowest point is 2.76, if broken, there might be a short-term retracement to 2.65-2.70.
📊 Technical analysis: There is support, but lacks breakthrough momentum.
• MA20 (2.642) is the first support level, if broken, look at the 2.60 level.
• MA250 (1.320) is much lower than the current stock price, indicating that it is still in a long-term rebound phase, but lacks the characteristics of a strong uptrend.
• Volume 8.483 million, decreased compared to the previous few days, indicating intensified wait-and-see sentiment between longs and shorts.
⚠️ Key variable: 2/26 Earnings Reports
• Before the Earnings Reports, there may be market games. If the Earnings Reports are not good, there may be a direct plunge, so short-term caution is even more important.
• If the Volume breaks through 2.96 before the Earnings Reports, short-term follow-up can be considered, otherwise, it is safer to wait until after the Earnings Reports to operate.
Smart strategy of senior stock investor
📌 Conservative strategy (buy low and wait for stability)
✅ Consider buying only after it stabilizes at 2.65-2.70...
Translated
19